Ani Pharmaceuticals (ANIP) Asset Utilization Ratio (2011 - 2026)

Ani Pharmaceuticals has disclosed Asset Utilization Ratio across 16 years of filings, most recently posting 0.67 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio rose 18.31% year-over-year to 0.67; the TTM figure through Jun 2026 stood at 0.67 (up 18.31% YoY), while the FY2025 annual figure was 0.65, up 15.5% from the prior year.
• Asset Utilization Ratio came in at 0.67 for Q2 2026 at Ani Pharmaceuticals, up from 0.65 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.67 in Q2 2026 to a low of 0.3 in Q1 2022.
• Average Asset Utilization Ratio over 5 years is 0.51, with a median of 0.52 recorded in 2023.
• Year-over-year, Asset Utilization Ratio tumbled 35.32% in 2022 and surged 57.73% in 2023.
• Over 5 years, Asset Utilization Ratio stood at 0.42 in 2022, then grew by 28.56% to 0.54 in 2023, then decreased by 11.95% to 0.48 in 2024, then advanced by 29.82% to 0.62 in 2025, then rose by 8.19% to 0.67 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.67 in Q2 2026, 0.65 in Q1 2026, and 0.62 in Q4 2025.